Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 8;10(4):730.
doi: 10.3390/plants10040730.

Bitter Melon (Momordica charantia L.) Fruit Bioactives Charantin and Vicine Potential for Diabetes Prophylaxis and Treatment

Affiliations

Bitter Melon (Momordica charantia L.) Fruit Bioactives Charantin and Vicine Potential for Diabetes Prophylaxis and Treatment

Mahwish et al. Plants (Basel). .

Abstract

Natural products are gaining clinical significance in modern day health care systems to prevent diseases. Bitter melon, a health promoting vegetable, is traditionally used for medical nutrition therapy to cure diabetes but to reap maximum health claims, vigilant control of its substances in diet is crucial as part of curative action for effective diabetes management. In the present research, first phase focused on detection of key bioactive components, i.e., charantin and vicine in different parts of its fruit. In the second phase, normal and hyperglycemic Sprague Dawley rats were fed on skin, flesh and whole fruit of bitter melon at 150 and 300 mg/kg body weight and assessed for diabetes prophylaxis and treatment. The highest amount of charantin (0.16 ± 0.02 mg/g) was recorded in flesh while vicine was present in abundance in whole fruit (0.21 ± 0.01 μg/100 g). In normal rats, bitter melon supplementation was helpful in managing the onset of diabetes. Hyperglycemic rats showed diabetic complications including polydipsia, polyuria, glycosuria, renal hypertrophy and increased glomerular filtration rate. However, bitter melon consumption showed significant improvements in these parameters. The most potent dose was 300 mg/kg whole fruit that resulted in 31.64% lowering of blood glucose level and 27.35% increase in insulin level in hyperglycemic rats.

Keywords: Momordica charantia; bitter melon; charantin; diabetes; glycemic control; hypoglycemia; vicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Charantin and vicine contents in skin, flesh and whole fruit of bitter melon. x,y,z indicated significant differences in charantin contents (p < 0.05); a,b,c indicated significant differences in vicine contents (p < 0.05).
Figure 2
Figure 2
Percent decrease in glucose level after feeding bitter gourd on 28th day. Bars that do not share similar letters denote statistical significance (p < 0.05).
Figure 3
Figure 3
Percent decrease in glucose level after feeding bitter gourd on 56th day. Bars that do not share similar letters denote statistical significance (p < 0.05).
Figure 4
Figure 4
Percent increase in insulin level after feeding bitter gourd on 28th day. Bars that do not share similar letters denote statistical significance (p < 0.05).
Figure 5
Figure 5
Percent increase in insulin level after feeding bitter gourd on 56th day. Bars that do not share similar letters denote statistical significance (p < 0.05).

Similar articles

Cited by

References

    1. Grover J.K., Yadav S., Vats V. Medicinal plants of India with anti-diabetic potential. J. Ethnopharmacol. 2002;81:81–100. doi: 10.1016/S0378-8741(02)00059-4. - DOI - PubMed
    1. Gupta M., Sharma S., Gautam A., Bhadauria R. Momordica charantia Linn. (Karela): Nature’s silent healer. Int. J. Pharm. Sci. Rev. Res. 2011;11:32–37.
    1. Virdi J., Sivakami S., Shahani S., Suthar A.C., Banavalikar M.M., Biyani M.K. Antihyperglycemic effects of three extracts from Momordica charantia. J. Ethnopharmacol. 2003;88:107–111. doi: 10.1016/S0378-8741(03)00184-3. - DOI - PubMed
    1. Kulkarni P., Lohidasan S., Mahadik K. Isolation, characterisation and investigation of in vitro antidiabetic and antioxidant activity of phytoconstituents from fruit of Momordica charantia Linn. Nat. Prod. Res. 2019:1–3. doi: 10.1080/14786419.2019.1613400. - DOI - PubMed
    1. Kim S.K., Jung J., Jung J.H., Yoon N., Kang S.S., Roh G.S., Hahm J.R. Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus. Complement. Ther. Med. 2020;52:102524. doi: 10.1016/j.ctim.2020.102524. - DOI - PubMed

LinkOut - more resources